Your browser doesn't support javascript.
loading
ASXL1 gene alterations in patients with isolated 20q deletion.
Brezinova, J; Sarova, I; Svobodova, K; Lhotska, H; Ransdorfova, S; Izakova, S; Pavlistova, L; Lizcova, L; Skipalova, K; Hodanova, L; Markova, J; Zemanova, Z; Cermak, J; Jonasova, A; Michalova, K.
Afiliação
  • Brezinova J; Department of Cytogenetics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Sarova I; Department of Cytogenetics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Svobodova K; Center of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
  • Lhotska H; Center of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
  • Ransdorfova S; Department of Cytogenetics, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Izakova S; Center of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
  • Pavlistova L; Center of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
  • Lizcova L; Center of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
  • Skipalova K; Center of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
  • Hodanova L; Center of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
  • Markova J; Clinical Department, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Zemanova Z; Center of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
  • Cermak J; Clinical Department, Institute of Hematology and Blood Transfusion, Prague, Czech Republic.
  • Jonasova A; 1st Medical Department, General University Hospital and First Faculty of Medicine , Charles University in Prague, Prague, Czech Republic.
  • Michalova K; Center of Oncocytogenetics, Institute of Medical Biochemistry and Laboratory Diagnostics, General University Hospital and First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.
Neoplasma ; 66(4): 627-630, 2019 07 23.
Article em En | MEDLINE | ID: mdl-30868899
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Síndromes Mielodisplásicas / Cromossomos Humanos Par 20 / Deleção Cromossômica Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas Repressoras / Síndromes Mielodisplásicas / Cromossomos Humanos Par 20 / Deleção Cromossômica Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article